Thymus longevity AI cancer immunity research 2026 | Healthcare Discovery
| | |

The Forgotten Organ: How AI Just Revealed the Thymus as a Master Regulator of Longevity and Cancer Survival

Two landmark studies published in Nature used AI-powered deep learning to show that thymic health predicts longevity, cardiovascular risk, and cancer immunotherapy outcomes, rewriting decades of assumptions about adult biology…

Deep sleep brain scan showing sleep spindles and glymphatic clearance protecting cognitive longevity
| | |

Adult Neurogenesis Confirmed: How 2026 Evidence Resolves the Hippocampus Debate and What It Means for Cognitive Longevity

For decades, neuroscience taught that the adult human brain was a closed shop: every neuron you would ever own was already wired by the time you finished puberty. A wave…

Luminous mitochondria undergoing quality control as NAD+ and MOTS-c signals support cellular aging
| | |

Spermidine and the Autophagy Switch: What 2026 Science Says About the Polyamine That May Mimic Caloric Restriction

Spermidine triggers autophagy, the cell’s recycling system, and a 20 year Austrian cohort linked higher dietary intake to roughly 5 fewer years of mortality. Inside the Frank Madeo Graz research,…

Scientists reviewing gene expression aging data in a DNA research laboratory | Healthcare Discovery
| | |

The First RAS Inhibitor to Beat Pancreatic Cancer: What Daraxonrasib’s Phase 3 Survival Data Means for Oncology

Revolution Medicines’ daraxonrasib achieved a median overall survival of 13.2 months versus 6.7 months for chemotherapy in previously treated metastatic pancreatic cancer, a 60 percent reduction in the risk of…

Senolytic therapy targeting senescent zombie cells in aging tissue during 2026 longevity clinical trials
| | |

Senolytics in 2026: How the Science of Killing Zombie Cells Reached Its First Human Proof of Concept

A decade of senolytic research is converging into something new. Inside the Mayo Clinic dasatinib quercetin work, the AFFIRM-LITE fisetin trial, Rubedo’s March 2026 Phase 1 readout of RLS-1496, and…

Diet reverses biological age in older adults nutrition longevity study | Healthcare Discovery
| |

Young Blood Revisited: Inside the 2026 Trials Testing Plasma Exchange and Rejuvenation Factors

A decade after parabiosis lit up the longevity field, the science of young blood has matured into rigorous plasma exchange trials, recombinant rejuvenation factors, and a quietly revealing exercise literature….

Healthcare Discovery PEARL trial rapamycin human aging results showing older adults in a clinical longevity research setting
| | |

The PEARL Trial Is In: What Low-Dose Rapamycin Actually Did to Human Aging Over 48 Weeks

The most anticipated longevity drug trial in a generation has delivered its full one-year results. Here is what rapamycin actually did to lean muscle, pain, biological age, and overall healthspan…

Healthcare Discovery MechanoAge breast cancer AI mechanical age risk showing cells measured in a microfluidic diagnostic platform
| | |

Your Cells Have a Mechanical Age, and AI Can Now Read It to Predict Breast Cancer Risk

A UC Berkeley and City of Hope team published a landmark AI platform called MechanoAge in Lancet’s eBioMedicine that measures the physical stress-response of individual breast cells to identify cancer…

AI emergency room diagnosis Harvard study 2026 | Healthcare Discovery
| | |

AI Is Now Building Drugs That Target Aging Itself: Inside the Longevity Board and the New Science of Healthspan Medicine

A Nobel laureate on its board. The world’s largest pharmaceutical company as a founding partner. And a scientific mission to build drugs that target aging itself. Inside Insilico Medicine’s Longevity…

Senolytic therapy targeting senescent zombie cells in aging tissue during 2026 longevity clinical trials
| | |

Senolytics in 2026: Inside the Clinical Trials Targeting Zombie Cells to Extend Healthy Lifespan

More than 30 senolytic and senomorphic clinical trials are now active, spanning diabetic macular edema, pulmonary fibrosis, osteoarthritis, and frailty. Inside the science of zombie cells, the first-generation compounds from…